By G HossainPosted on September 3, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs After spinning out of BridgeBio in May 2024, BBOT had an eye on another round of fundraising in 2025. A SPAC quickly emerged as the best option. After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute Post navigation In the blogs: It’s all in the gameAfter 2021 SPAC Bubble, How Did These 6 Biotechs Fare?